GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLDX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Celldex Therapeutics stock after losing 1.43%
(Updated on Apr 19, 2024)

Sell candidate since Apr 18, 2024 Loss -1.43% PDF

The Celldex Therapeutics stock price fell by -1.43% on the last day (Friday, 19th Apr 2024) from $38.53 to $37.98. During the last trading day the stock fluctuated 4.58% from a day low at $36.78 to a day high of $38.47. The price has fallen in 6 of the last 10 days and is down by -4.04% for this period. Volume has increased on the last day by 53 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 589 thousand shares were bought and sold for approximately $22.37 million.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $37.88 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 7.01% during the next 3 months and, with a 90% probability hold a price between $40.54 and $57.58 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLDX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Celldex Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $39.13 and $42.49. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -26.79%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Celldex Therapeutics stock

Celldex Therapeutics finds support from accumulated volume at $37.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.69 between high and low, or 4.58%. For the last week, the stock has had daily average volatility of 3.94%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLDX) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Celldex Therapeutics to open at $37.74, and during the day (based on 14 day Average True Range), to move between $36.13 and $39.83, which gives a possible trading interval of +/-$1.85 (+/-4.87%) up or down from last closing price. If Celldex Therapeutics takes out the full calculated possible swing range there will be an estimated 9.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $37.75 (0.61%) than the resistance at $38.25 (0.71%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Celldex Therapeutics stock A Buy?

The Celldex Therapeutics stock holds several negative signals and despite the positive trend, we believe Celldex Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.094 Sell Candidate Unchanged

Predicted Opening Price for Celldex Therapeutics of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$37.74 ( 0.628%) $37.98

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLDX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 39.43 3.81 %
R2 38.78 2.11 %
R1 38.39 1.07 %
Current price: 37.98
Support S1 37.10 -2.32 %
S2 36.70 -3.37 %
S3 36.06 -5.06 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 42.01 10.61 %
R2 41.16 8.37 %
R1 38.25 0.711 %
Current price 37.98
Support S1 37.75 -0.606%
S2 37.20 -2.05%
S3 36.38 -4.21%

FAQ

What is the symbol for Celldex Therapeutics Stock and on which exchange is it traded?
The symbol for Celldex Therapeutics is CLDX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Celldex Therapeutics Stock?
The Celldex Therapeutics stock holds several negative signals and despite the positive trend, we believe Celldex Therapeutics will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Celldex Therapeutics Stock?
Celldex Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Celldex Therapeutics Stock.

What's the current price of Celldex Therapeutics Stock?
As of the end of day on the 2024-04-19, the price of an Celldex Therapeutics (CLDX) share was $37.98.

What is the 52-week high and low for Celldex Therapeutics Stock?
The 52-week high for Celldex Therapeutics Stock is $53.18 and the 52-week low is $22.11.

What is the market capitalization of Celldex Therapeutics Stock?
As of the 2024-04-19, the market capitalization of Celldex Therapeutics is 2.553B.

When is the next earnings date for Celldex Therapeutics?
The upcoming earnings date for Celldex Therapeutics is May 02, 2024.
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT